Staar Surgical Q2 Adj EPS $0.40 Beats $0.32 Estimate, Sales $92.31M Miss $93.04M Estimate
Portfolio Pulse from bharat@benzinga.com
Staar Surgical (NASDAQ:STAA) reported Q2 earnings of $0.40 per share, beating the analyst consensus estimate of $0.32 by 25%. However, this is a 4.76% decrease from the same period last year. The company's quarterly sales of $92.31 million missed the analyst consensus estimate of $93.04 million by 0.79%, but it's a 13.82% increase from the same period last year.
August 04, 2023 | 12:14 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Staar Surgical's Q2 earnings beat estimates but sales missed. While the earnings per share were higher than expected, they were lower than the same period last year. Sales, although higher than last year, missed estimates.
Staar Surgical's Q2 results are mixed, with earnings beating estimates but lower than last year, and sales missing estimates but higher than last year. This could lead to uncertainty among investors, potentially impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100